In randomized trials in patients with atrial fibrillation (AF), treatment strategies that restore and maintain sinus rhythm (rhythm control) have not shown convincing advantages over those that simply ...

Clinical Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical practice and improve patient ...

Old concerns about the safety of rhythm control drugs for atrial fibrillation (Afib or AF) resurfaced in a contemporary large Korean population-based study. Afib patients prescribed antiarrhythmic ...

A recent randomized trial in Czechia tested the premise that lifestyle modification and use of antiarrhythmic drugs was as effective as catheter ablation (CA) to treat atrial fibrillation (AF). The ...

The American College of Cardiology (ACC) and the American Heart Association (AHA), along with several other leading medical associations, have issued a new guideline for preventing and optimally ...

Low concentrations of three selected biomarkers in the blood of patients with atrial fibrillation identify patients with a high chance of attaining sinus rhythm. This is the main result of this ...

Atrial fibrillation (AFib) can lead to blood clots, stroke, heart failure, and other heart-related complications. New consumer patient research from the Dallas-based American Heart Association found ...

Irregular heartbeat conditions affect millions of people worldwide, causing hearts to beat too fast, too slow, or with an uneven rhythm. These cardiac rhythm disturbances, medically known as ...